Abstract:Objective: Vascular endothelial growth factor is a potent stimulator of angiogenesis; activation of hypoxia inducible factor-1 alpha and p44/42 mitogen-activated protein kinase pathways has been associated with vascular endothelial growth factor production. The present study examined if thrombin modulates vascular endothelial growth factor levels in gliomas via hypoxia inducible factor-1 alpha and p44/42 mitogen-activated protein kinase pathways.Methods: This study was divided into two parts: (1) adult male Fischer 344 rats had an intracaudatal implantation of C6 glioma cells. Rats were killed 6, 9 and 12 days later for Western blotting and immunohistochemistry. Hypoxia inducible factor-1 alpha messenger ribonucleic acid was also determined; (2) cultured C6 cells were treated with vehicle, thrombin, thrombin plus YC-1, an inhibitor of hypoxia inducible factor-1 alpha, or thrombin plus PD098059, an inhibitor of p44/42 mitogen-activated protein kinases. Cell culture medium was collected for vascular endothelial growth factor measurement using an enzyme-linked immunosorbent assay kit.Results: In vivo, immunoreactivities for thrombin, vascular endothelial growth factor, hypoxia inducible factor-1 alpha and activated p44/42 mitogen-activated protein kinases were detected in C6 gliomas. Thrombin immunoreactivity was co-localized with that of vascular endothelial growth factor, hypoxia inducible factor-1 alpha or activated p44/42 mitogen-activated protein kinases. A time course showed that activated p44/42 mitogen-activated protein kinases and vascular endothelial growth factor protein levels increased in gliomas with time. Hypoxia inducible factor-1 alpha protein levels were higher in C6 gliomas than those in the contralateral brain tissue. In vitro, thrombin exposure increased the levels of vascular endothelial growth factor, hypoxia inducible factor-1 alpha and activated p44/42 mitogen-activated protein kinases in C6 cells. Thrombin-induced vascular endothelial growth factor up-regulation was blocked by YC-1 and PD098059.Discussion: Thrombin activates hypoxia inducible factor-1 alpha and p44/42 mitogen-activated protein kinase pathways, and up-regulates vascular endothelial growth factor in gliomas. Inhibiting hypoxia inducible factor-1 alpha and p44/42 mitogen-activated protein kinase pathways reduces the thrombin-induced up-regulation of vascular endothelial growth factor. These results suggest thrombin can increase vascular endothelial growth factor levels via activating hypoxia inducible factor-1 alpha and p44/42 mitogen-activated protein kinase pathways in gliomas. [Neurol Res 2009; 31: 759-765]

Γ-Secretase Inhibitor Up-Regulates Vascular Endothelial Growth Factor Receptor-2 and Endothelial Nitric Oxide Synthase

Gamma-secretase Inhibitor DAPT Suppresses Glioblastoma Growth Via Uncoupling of Tumor Vessel Density from Vessel Function

Concurrent Treatment with Anti-DLL4 Enhances Antitumor and Proapoptotic Efficacy of a Γ-Secretase Inhibitor in Gastric Cancer.

Hvegf Sirna Inhibits Initial Growth of A549 Tumor Cells in Nude Mice and Angiogenesis on CAM Assay

Combination of Stromal-Derived Factor-1Α and Vascular Endothelial Growth Factor Gene-Modified Endothelial Progenitor Cells is More Effective for Ischemic Neovascularization

Down-Regulation Of Notch Signaling By A Gamma-Secretase Inhibitor Enhances The Radiosensitivity Of Nasopharyngeal Carcinoma Cells

Inhibition of Gamma-Secretase in Notch1 Signaling Pathway As a Novel Treatment for Ovarian Cancer

Thrombin Up-Regulates Vascular Endothelial Growth Factor in Experimental Gliomas

Inhibition of Vascular Smooth Muscle and Cancer Cell Proliferation by New VEGFR Inhibitors and Their Immunomodulator Effect: Design, Synthesis, and Biological Evaluation

DAPT Suppresses the Proliferation of Human Glioma Cell Line SHG-44.

Angiopoietin-2 facilitates vascular endothelial growth factor-induced angiogenesis in the mature mouse brain.

VEGFR endocytosis regulates the angiogenesis in a mouse model of hindlimb ischemia

Downregulation of Astrocyte Elevated Gene-1 Expression Combined with All-Trans Retinoic Acid Inhibits Development of Vasculogenic Mimicry and Angiogenesis in Glioma.

Phosphorylation of Dab2 is Involved in Inhibited VEGF‐VEGFR‐2 Signaling Induced by Downregulation of Syndecan‐1 in Glomerular Endothelial Cell

A novel transcriptional complex on the VE-cadherin promoter regulated the downregulation of VE-cadherin in the Down Syndrome Candidate Region 1 isoform 1L-mediated angiogenesis

VEGF Secretion by Neuroendocrine Tumor Cells Is Inhibited by Octreotide and by Inhibitors of the PI3K/AKT/mTOR Pathway

Gamma-secretase inhibitor, a potential target therapy for MUC2-positive colorectal carcinoma

IL6 blockade potentiates the anti-tumor effects of γ -secretase inhibitors in Notch3-expressing breast cancer

Inhibition Of Tumor-Induced Edema By Antisense Vegf Is Mediated By Suppressive Vesiculo-Vacuolar Organelles (Vvo) Formation

Interferon Alpha 2a Downregulates Vegf Expression Through Pi3 Kinase and Map Kinase Signaling Pathways

Silencing of PTGS2 exerts promoting effects on angiogenesis endothelial progenitor cells in mice with ischemic stroke via repression of the NF‐κB signaling pathway